Influence of adjuvants on the induction of autoantibodies to the thyrotropin receptor.

To determine the influence of adjuvant on the induction of antibodies to thyrotropin receptor (TSHR), we immunized BALB/c mice with a extracellular domain of the TSHR (ETSHR) protein in complete Freund's adjuvant (CFA), Titer Max (TM) and Gerbu. Similarly, control groups of mice were immunized with bovine serum albumin (BSA) in each of the different adjuvants. As determined by ELISA, ETSHR given along with CFA elicited high titers of antibodies to ETSHR which were mainly restricted to the IgG1 subclass. Mice immunized with ETSHR in TM also developed high titers of anti-ETSHR antibodies but had higher levels of both IgG1 and IgG2a. However, immunization with ETSHR in Gerbu resulted in low titers of antibodies, restricted to IgG1 subclass. Immunization of mice with BSA in each of the three adjuvants induced higher antibody titers to BSA. The subclass of antibodies in mice immunized with BSA in CFA and TM were predominantly IgG1 and IgG2a with lower levels of IgG2b, whereas in Gerbu treated group, antibody to BSA was restricted to IgG1 subclass. Analysis of specificity of antibodies against ETSHR, in mice immunized with ETSHR, revealed that irrespective of the adjuvant used, the dominant reactivity was against peptide 1 (AA 22-41) with weaker reactivity against several other. peptides. The only exception was in mice immunized with ETSHR in TM which also showed significant reactivity against peptide 23 (AA 352-371). Mice immunized with the ETSHR in CFA or in TM showed elevated levels of serum TSH binding inhibitory immunoglobulins (TBII). However, mice immunized with ETSHR in Gerbu, which had lower titers of antibodies to ETSHR, showed normal TBII levels. These studies showed that adjuvant composition could influence the titer, subclass and fine specificity of antibodies to ETSHR which in turn could affect the development of TBII activity.

[1]  Y. Tomer,et al.  Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading. , 1995, Endocrinology.

[2]  B. Prabhakar,et al.  Thyrotropin receptor-specific antibodies in BALB/cJ mice with experimental hyperthyroxinemia show a restricted binding specificity and belong to the immunoglobulin G1 subclass. , 1995, Endocrinology.

[3]  B. Prabhakar,et al.  Generation and characterization of monoclonal antibodies to the human thyrotropin (TSH) receptor: antibodies can bind to discrete conformational or linear epitopes and block TSH binding. , 1995, Endocrinology.

[4]  T. Scott,et al.  Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves’ disease , 1995, Clinical and experimental immunology.

[5]  N. Grubhofer An adjuvant formulation based on N-acetylglucosaminyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with dimethyldioctadecylammonium chloride and zinc-L-proline complex as synergists. , 1995, Immunology letters.

[6]  M. Tonacchera,et al.  Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model. , 1994, Endocrinology.

[7]  G. Nest,et al.  Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. , 1994, Journal of immunology.

[8]  L. Kohn,et al.  Induction of autoimmunity by immunization of mice with human thyrotropin receptor. , 1994, Cellular immunology.

[9]  M. Tonacchera,et al.  Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R. , 1994, Biochemical and biophysical research communications.

[10]  R. Goldblum,et al.  Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and function. , 1994, Endocrinology.

[11]  A. Kurosky,et al.  A recombinant extracellular domain of the thyrotropin (TSH) receptor binds TSH in the absence of membranes. , 1994, Endocrinology.

[12]  B. Prabhakar,et al.  Induction of hyperthyroxinemia in BALB/C but not in several other strains of mice. , 1994, Autoimmunity.

[13]  J. Morris,et al.  Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides. , 1993, The Journal of biological chemistry.

[14]  B. Prabhakar,et al.  Induction of TSH binding inhibitory immunoglobulins with the extracellular domain of human thyrotropin receptor produced using baculovirus expression system. , 1993, Autoimmunity.

[15]  B. Prabhakar,et al.  Analysis of autoantibody reactivity in patients with Graves' disease using recombinant extracellular domain of the human thyrotropin receptor and synthetic peptides. , 1993, Autoimmunity.

[16]  T. Andronova,et al.  The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants. , 1992, AIDS research and human retroviruses.

[17]  R. Hunter,et al.  A comparison of commercially available adjuvants for use in research. , 1992, Journal of immunological methods.

[18]  K. P. Singh,et al.  Effect of zinc on immune functions and host resistance against infection and tumor challenge. , 1992, Immunopharmacology and immunotoxicology.

[19]  R. Hunter,et al.  Murine IgG isotype responses to the Plasmodium cynomolgi circumsporozoite peptide (NAGG)5. I. Effects of carrier, copolymer adjuvants, and lipopolysaccharide on isotype selection. , 1991, Journal of immunology.

[20]  M. Dufau,et al.  Factors that Regulate the Development of Testicular Autoimmune Diseases a , 1984, Annals of the New York Academy of Sciences.

[21]  B. Smith,et al.  A RECEPTOR ASSAY FOR THE MEASUREMENT OF TSH RECEPTOR ANTIBODIES IN UNEXTRACTED SERUM , 1984, Clinical endocrinology.

[22]  E. Simpson,et al.  Murine models of multiple sclerosis , 1982, Nature.

[23]  P. Christadoss,et al.  GENETIC CONTROL OF AUTOIMMUNITY TO ACETYLCHOLINE RECEPTORS: ROLE OF Ia MOLECULES * , 1981, Annals of the New York Academy of Sciences.

[24]  E. Lederer,et al.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. , 1974, Biochemical and biophysical research communications.

[25]  E. Lederer,et al.  Adjuvant activity of monomeric bacterial cell wall peptidoglycans. , 1974, Biochemical and biophysical research communications.

[26]  J. Patrick,et al.  Autoimmune Response to Acetylcholine Receptor , 1973, Science.

[27]  N. Rose,et al.  Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. , 1971, Journal of immunology.

[28]  E. D. Exum,et al.  THE RELATIONSHIP OF DELAYED HYPERSENSITIVITY AND CIRCULATING ANTIBODY TO EXPERIMENTAL ALLERGIC THYROIDITIS IN INBRED GUINEA PIGS , 1961, The Journal of experimental medicine.

[29]  J. Freund The mode of action of immunologic adjuvants. , 1956, Bibliotheca tuberculosea.

[30]  J. Freund,et al.  Isoallergic encephalomyelitis and radiculitis in guinea pigs after one injection of brain and Mycobacteria in water-in-oil emulsion. , 1947, Journal of immunology.